These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 17582439
1. Stem cell treatment in Amyotrophic Lateral Sclerosis. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, Fagioli F. J Neurol Sci; 2008 Feb 15; 265(1-2):78-83. PubMed ID: 17582439 [Abstract] [Full Text] [Related]
2. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Choi MR, Kim HY, Park JY, Lee TY, Baik CS, Chai YG, Jung KH, Park KS, Roh W, Kim KS, Kim SH. Neurosci Lett; 2010 Mar 19; 472(2):94-8. PubMed ID: 20117176 [Abstract] [Full Text] [Related]
4. Is it too soon for mesenchymal stem cell trials in people with ALS? Badayan I, Cudkowicz ME. Amyotroph Lateral Scler; 2008 Dec 19; 9(6):321-2. PubMed ID: 18819027 [Abstract] [Full Text] [Related]
5. A novel cell transplantation protocol and its application to an ALS mouse model. Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, Fukada Y, Doi K, Karunaratne A, Murrell WG, Sutharsan R, Mackay-Sim A, Hata Y, Nakashima K. Exp Neurol; 2008 Oct 19; 213(2):431-8. PubMed ID: 18691571 [Abstract] [Full Text] [Related]
7. [Bone marrow stem cell transplantation in amyotrophic lateral sclerosis: technical aspects and preliminary results from a clinical trial]. Blanquer M, Pérez Espejo MA, Iniesta F, Gómez Espuch J, Meca J, Villaverde R, Izura V, de Mingo P, Martínez-Lage J, Martínez S, Moraleda JM. Methods Find Exp Clin Pharmacol; 2010 Dec 19; 32 Suppl A():31-7. PubMed ID: 21381286 [Abstract] [Full Text] [Related]
8. The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Gan Y, Dai K, Zhang P, Tang T, Zhu Z, Lu J. Biomaterials; 2008 Oct 19; 29(29):3973-82. PubMed ID: 18639333 [Abstract] [Full Text] [Related]
11. Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis: a pilot study. Prabhakar S, Marwaha N, Lal V, Sharma RR, Rajan R, Khandelwal N. Neurol India; 2012 Oct 19; 60(5):465-9. PubMed ID: 23135021 [Abstract] [Full Text] [Related]
12. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH. Stem Cells Transl Med; 2015 Jun 19; 4(6):590-7. PubMed ID: 25934946 [Abstract] [Full Text] [Related]
16. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D. JAMA Neurol; 2016 Mar 19; 73(3):337-44. PubMed ID: 26751635 [Abstract] [Full Text] [Related]
17. Toward the treatments with neural stem cells: experiences from amyotrophic lateral sclerosis. Mitrecić D, Gajović S, Pochet R. Anat Rec (Hoboken); 2009 Dec 19; 292(12):1962-7. PubMed ID: 19943351 [Abstract] [Full Text] [Related]
18. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Neurology; 2009 Jun 02; 72(22):1948-52. PubMed ID: 19487653 [Abstract] [Full Text] [Related]
19. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, Simpson EP, Luo Y, Carrum G, Heslop HE, Brenner MK, Popat U. Neurology; 2008 Oct 21; 71(17):1326-34. PubMed ID: 18936424 [Abstract] [Full Text] [Related]